JP2010538019A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538019A5
JP2010538019A5 JP2010523180A JP2010523180A JP2010538019A5 JP 2010538019 A5 JP2010538019 A5 JP 2010538019A5 JP 2010523180 A JP2010523180 A JP 2010523180A JP 2010523180 A JP2010523180 A JP 2010523180A JP 2010538019 A5 JP2010538019 A5 JP 2010538019A5
Authority
JP
Japan
Prior art keywords
cation
compound
formula
ammonium
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538019A (ja
JP5509080B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/074914 external-priority patent/WO2009029888A2/en
Publication of JP2010538019A publication Critical patent/JP2010538019A/ja
Publication of JP2010538019A5 publication Critical patent/JP2010538019A5/ja
Application granted granted Critical
Publication of JP5509080B2 publication Critical patent/JP5509080B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523180A 2007-08-31 2008-08-29 抗インフルエンザ活性を有するオセルタミビル含有ホスホネートコンジナーの合成 Expired - Fee Related JP5509080B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96949107P 2007-08-31 2007-08-31
US60/969,491 2007-08-31
US4850708P 2008-04-28 2008-04-28
US61/048,507 2008-04-28
PCT/US2008/074914 WO2009029888A2 (en) 2007-08-31 2008-08-29 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity

Publications (3)

Publication Number Publication Date
JP2010538019A JP2010538019A (ja) 2010-12-09
JP2010538019A5 true JP2010538019A5 (https=) 2011-10-13
JP5509080B2 JP5509080B2 (ja) 2014-06-04

Family

ID=40388153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523180A Expired - Fee Related JP5509080B2 (ja) 2007-08-31 2008-08-29 抗インフルエンザ活性を有するオセルタミビル含有ホスホネートコンジナーの合成

Country Status (8)

Country Link
US (1) US7888337B2 (https=)
EP (1) EP2190439B1 (https=)
JP (1) JP5509080B2 (https=)
KR (1) KR101535691B1 (https=)
CN (1) CN101883569B (https=)
AU (1) AU2008292859C1 (https=)
CA (1) CA2697837C (https=)
WO (1) WO2009029888A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカAcademia Sinica Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
CN103068378B (zh) * 2010-05-10 2016-07-06 中央研究院 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法
US8515882B2 (en) 2010-11-18 2013-08-20 International Business Machines Corporation Efficient storage of individuals for optimization simulation
US8489526B2 (en) 2010-11-24 2013-07-16 International Business Machines Corporation Controlling quarantining and biasing in cataclysms for optimization simulations
US9563844B2 (en) 2011-06-30 2017-02-07 International Business Machines Corporation Speculative asynchronous sub-population evolutionary computing utilizing a termination speculation threshold
KR101331167B1 (ko) * 2011-08-26 2013-11-19 주식회사 씨트리 신규한 오셀타미비르 유도체 및 그 제조방법
DE102011117128A1 (de) * 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
US9165247B2 (en) 2012-01-04 2015-10-20 International Business Machines Corporation Using global and local catastrophes across sub-populations in parallel evolutionary computing
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CN103848762B (zh) * 2012-11-30 2016-08-31 北京普禄德医药科技有限公司 神经氨酸苷酶抑制剂的前药及其组合物和用途
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
US9305257B2 (en) 2013-05-20 2016-04-05 International Business Machines Corporation Adaptive cataclysms in genetic algorithms
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
US9782476B2 (en) 2013-09-06 2017-10-10 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015148915A1 (en) 2014-03-27 2015-10-01 Academia Sinica Reactive labelling compounds and uses thereof
KR102512592B1 (ko) 2014-05-27 2023-03-21 아카데미아 시니카 항-her2 글리코항체 및 이의 용도
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-cd20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950423A1 (en) 2014-05-27 2015-12-03 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CN106714829A (zh) 2014-05-28 2017-05-24 中央研究院 抗TNF‑α醣抗体及其用途
CA2960712A1 (en) 2014-09-08 2016-03-17 Academia Sinica Human inkt cell activation using glycolipids
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
EP3500594A4 (en) 2016-08-22 2020-03-11 Cho Pharma Inc. ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
CN114315626A (zh) * 2021-12-21 2022-04-12 艾希尔(深圳)药物研发有限公司 一种奥司他韦脱烷基杂质的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US20080009639A1 (en) 2006-07-10 2008-01-10 Apotex Pharmachem Inc. Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose

Similar Documents

Publication Publication Date Title
JP2010538019A5 (https=)
JP5343925B2 (ja) (2r)−2−プロピルオクタン酸の製造方法
US8058412B2 (en) Dehydroxyfluorination agent
JP7161466B2 (ja) グリコピロニウム化合物を作製するための方法及び使用する方法
CN111233829A (zh) 一种具有光学活性的尼古丁的制备方法
ES2494865T3 (es) Método para producir alfa-aminoácido que contiene fósforo e intermedio de producción del mismo
JPH05331128A (ja) (R)−(−)−4−シアノ−3−ヒドロキシ酪酸t−ブチルエステル及びその製造方法
US8835672B2 (en) Manufacture of a triiodinated contrast agent
DE102012202885B4 (de) Herstellung von Menthancarbonaldehyd, Menthancarbonsäure und Folgeprodukten
EP3772511B1 (en) Process for the preparation of a nitric oxide donating prostaglandin analogue
JP2710688B2 (ja) 4―ブロモ―3―ヒドロキシ酪酸エステル誘導体の製造法
CN103003257B (zh) 用于由β-内酯生产肉碱的方法
CN114560894B (zh) 一种抗新冠药物Molnupiravir的制备方法
US9242950B2 (en) Method for preparing a fatty acid derivative
WO2013093220A1 (fr) Procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
JP2009215239A (ja) オセルタミビル及びその類縁化合物の製造方法
Gee et al. Oxidative ring-opening of ferrocenylcyclopropylamines to N-ferrocenylmethyl β-hydroxyamides
JP4320443B2 (ja) アリルグリシン又はその類縁体を製造する方法
JP3899626B2 (ja) 2−メルカプトチアゾ−ルの製法
US11891409B2 (en) Trifluoromethyl alkenylphosphonate and preparation method therefor
JP4023255B2 (ja) ジカルボン酸の製造方法とそれに用いる触媒の製造方法
JP4643566B2 (ja) N−アシルヒドラゾンのアリル化方法
KR101023455B1 (ko) 라세믹 또는 광학적으로 활성이 있는 α―글리세로포스포릴콜린의 제조방법
EP1951654B1 (en) Improved process for oseltamivir phosphate
KR100673593B1 (ko) L-카르니틴의 제조방법